CCEP
Coca-Cola Europacific Partners PLC
There isn't enough reported data to score CCEP yet.
CCEP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Stable |
CCEP's profitability is currently strong, and its balance sheet is stable. There isn't enough data to rate its revenue and cash flow.
CCEP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $78.02 | -33% |
| Fair | 21x | $102 | -13% |
| Current | 24x | $117 | โ |
| Expensive | 27x | $128 | +9.8% |
Historical ranges are pointers, not guarantees.
CCEP's PE is 24x, but its earnings don't support one, so it isn't a reliable read right now.
CCEP Forward outlook
There aren't enough analyst estimates for CCEP to show an outlook.
CCEP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $4.73 | +38% |
| Q2 2025 | $3.71 | -4.6% |
| Q4 2024 | $3.42 | -15% |
| Q2 2024 | $3.89 | -5.1% |
| Q4 2023 | $4.03 | +10% |
| Q2 2023 | $4.10 | +20% |
| Q4 2022 | $3.65 | +53% |
| Q2 2022 | $3.42 | +130% |
CCEP earned $4.73 per share over the past year, up 17% from the year before.
CCEP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.9B | +4.4% |
| Q4 2025 | $11.8B | +0.2% |
| Q2 2025 | $11.4B | +4.5% |
| Q4 2024 | $11.8B | +14% |
| Q2 2024 | $10.9B | +9.5% |
| Q4 2023 | $10.4B | +3.2% |
| Q2 2023 | $10B | +8.4% |
| Q4 2022 | $10B | +15% |
CCEP's revenue has grown year over year for 11 quarters in a row: $11.9B last quarter, up 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +2 points |
| Q4 2025 | 13% | +0.9 points |
| Q2 2025 | 13% | +0.3 points |
| Q4 2024 | 9.3% | -3.1 points |
| Q2 2024 | 12% | -0.1 points |
| Q4 2023 | 13% | -0.2 points |
| Q2 2023 | 13% | +4.2 points |
| Q4 2022 | 12% | +2.9 points |
CCEP's operating margin was 14% last quarter, up 2 points from the same quarter a year ago, near the top of its range since 2012.
CCEP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $670.7M | -6.1% |
| Q4 2025 | $1.7B | +1.4% |
| Q2 2025 | $714.3M | -12% |
| Q4 2024 | $1.7B | +41% |
| Q2 2024 | $813.2M | -30% |
| Q4 2023 | $1.2B | +14% |
| Q2 2023 | $1.2B | -29% |
| Q4 2022 | $1.1B | -1.8% |
CCEP generated $4.8B in free cash flow over the past year, up 14% from the year before.
CCEP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 2.6x | Moderate |
| Q2 2025 | 3.1x | Elevated |
| Q4 2024 | 3.2x | Elevated |
| Q2 2024 | 3.3x | Elevated |
| Q4 2023 | 3.2x | Elevated |
| Q2 2023 | 3.4x | Elevated |
| Q4 2022 | 3.6x | Elevated |
| Q2 2022 | 3.9x | Elevated |
CCEP's net debt is about 2.6 years of its operating earnings (EBITDA), down from 3.2 years a year ago.
CCEP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.2 | Neutral |
| Stochastic | 88.6 | Overbought |
CCEP's weekly RSI is 67 (neutral) and its Stochastic is 89 (overbought).
CCEP PE vs Consumer Defensive Sector
| Metric | CCEP | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 19x | 22% above |
| PE % | 71 | 18 | 53 pts above |
CCEP is trading at 24x earnings, a 22% premium to the Consumer Defensive sector's median of 19x, though its earnings don't support one.
CCEP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $109.6 | 6.7% above |
| 20 week MA | $107.5 | 8.8% above |
| 50 week MA | $100.1 | 17% above |
| 100 week MA | $94.0 | 24% above |
| 200 week MA | $80.8 | 45% above |
CCEP is in an uptrend: it's above all five of its weekly moving averages, and 45% above its 200-week average.
CCEP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.9 | $47.7 | -6.3% |
| 2021 | $47.7 | $55.2 | +16% |
| 2022 | $55.2 | $55.0 | -0.5% |
| 2023 | $55.0 | $66.7 | +21% |
| 2024 | $66.7 | $76.5 | +15% |
| 2025 | $76.5 | $91.7 | +20% |
| 2026 YTD | $91.7 | $116.9 | +28% |
CCEP has finished higher in four of the last six years. It's up 28% so far in 2026.